Article Details
Retrieved on: 2024-09-13 14:11:35
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article details the significant efficacy of ENHERTU, an antibody-drug conjugate co-developed by AstraZeneca and Daiichi Sankyo, in treating HER2-positive metastatic breast cancer, especially for patients with brain metastases. 'Natural medicine' is highlighted by the results being published in *Nature Medicine*.
Article found on: www.tipranks.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here